ArticleJournal of family medicine and primary care2026
Emerging antimicrobial resistance among
Article in Journal of family medicine and primary care, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: Acne vulgaris, a common skin disorder, primarily affects adolescents and often results in both inflammatory and noninflammatory lesions. Aims: This study aims to assess the AMR trends of Settings and Design: Setting: Tertiary care teaching hospital in Central India. Design: Observational cross-sectional study. Methods and Material: A total of 109 patients with pustular acne vulgaris were recruited over 15 months. Skin swabs were collected from lesions, cultured on Propionibacterium Isolation agar, and identified by conventional microbiological methods. Antimicrobial susceptibility testing (AST) was conducted using the Epsilometer test (E-test) to assess the AMR trends to clindamycin, erythromycin, doxycycline, and azithromycin. Results: Conclusions: This study highlights a significant concern regarding AMR in
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.